Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Galapagos (GLPG)

Galapagos
Date:
Sort by:
 Showing the most relevant articles for your search:EU:GLPG
DateTimeSourceHeadlineSymbolCompany
08/01/202506:30GlobeNewswire Inc.Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded EntitiesEU:GLPGGalapagos
07/01/202521:01GlobeNewswire Inc.Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceEU:GLPGGalapagos
07/12/202417:30GlobeNewswire Inc.Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin LymphomaEU:GLPGGalapagos
05/11/202421:01GlobeNewswire Inc.Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024EU:GLPGGalapagos
30/10/202420:01GlobeNewswire Inc.Galapagos Reports Third Quarter 2024 Financial Results and Provides Business UpdateEU:GLPGGalapagos
07/10/202405:00GlobeNewswire Inc.Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growthEU:GLPGGalapagos
30/09/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from EcoR1 CapitalEU:GLPGGalapagos
16/09/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from EcoR1 CapitalEU:GLPGGalapagos
03/09/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from FMR LLCEU:GLPGGalapagos
23/08/202405:00GlobeNewswire Inc.Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphomaEU:GLPGGalapagos
20/08/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from FMR LLCEU:GLPGGalapagos
01/08/202420:01GlobeNewswire Inc.Galapagos reports half-year 2024 financial results and provides second quarter business updateEU:GLPGGalapagos
14/06/202420:01GlobeNewswire Inc.Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024EU:GLPGGalapagos
14/06/202420:01GlobeNewswire Inc.Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024EU:GLPGGalapagos
30/05/202420:01GlobeNewswire Inc.Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indicationsEU:GLPGGalapagos
30/05/202420:01GlobeNewswire Inc.Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indicationsEU:GLPGGalapagos
16/05/202420:01GlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
16/05/202420:01GlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
15/05/202420:01GlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
15/05/202420:01GlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
02/05/202420:01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
02/05/202420:01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
30/04/202420:01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
30/04/202420:01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
04/04/202420:01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
04/04/202420:01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
28/03/202420:01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
28/03/202420:01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
26/03/202420:01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
26/03/202420:01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG